Childhood cardiometabolic outcomes of maternal obesity during pregnancy: the Generation R Study

Romy Gaillard1, Eric A P Steegers, Liesbeth Duijts

  • 1The Generation R Study Group (Na29-15), Erasmus Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands. v.jaddoe@erasmusmc.nl.

Insights

Maternal and paternal prepregnancy obesity are linked to poorer childhood cardiometabolic health. Maternal obesity showed stronger associations, suggesting direct intrauterine influences on offspring health.

Area of Science:

  • Pediatrics
  • Public Health
  • Genetics

Background:

  • Maternal prepregnancy obesity is linked to adverse offspring cardiometabolic health.
  • The role of intrauterine factors versus other influences remains unclear.

Purpose of the Study:

  • To examine associations of maternal and paternal prepregnancy BMI with offspring body composition and cardiometabolic outcomes.
  • To explore mediating factors including pregnancy, birth, and childhood characteristics.

Main Methods:

  • Population-based prospective cohort study of 4871 families.
  • Measured offspring BMI, body fat distribution, blood pressure, lipids, insulin, and C-peptide at age 6.
  • Analyzed associations with maternal and paternal prepregnancy BMI, adjusting for covariates.

Main Results:

  • Higher maternal and paternal BMI associated with increased childhood adiposity, blood pressure, and insulin levels.
  • Stronger associations observed for maternal BMI, suggesting potential intrauterine effects.
  • Associations attenuated after adjusting for childhood BMI, indicating its mediating role.

Conclusions:

  • Both maternal and paternal prepregnancy BMI are associated with adverse offspring cardiometabolic profiles.
  • Maternal prepregnancy BMI appears to have a stronger influence, possibly via intrauterine mechanisms.
  • Interventions targeting parental prepregnancy weight may improve long-term child health.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440